Pharmacokinetics, Safety, and Tolerability of Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatasvir in Healthy Chinese Subjects

Li, CY; Li, XJ; Zhu, XX; Zhang, H; Shen, G; Kersey, K; Ding, YH

Ding, YH (corresponding author), First Hosp Jilin Univ, Phase Clin Trial Unit 1, 71 Xinmin St, Changchun 130021, Jilin, Peoples R China.

CLINICAL THERAPEUTICS, 2020; 42 (3): 448

Abstract

Purpose: Ledipasvir/sofosbuvir and sofosbuvir/velpatasvir have been approved worldwide for the treatment of chronic hepatitis C virus (HCV) infection.......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索